Academic Perspectives on the Evolving Treatment Landscape in MPNs

An expert shares their perspective on the future of care for patients with myeloproliferative neoplasms (MPNs).

EP: 1.A 68-Year-Old Woman Diagnosed With Primary Myelofibrosis

EP: 2.Molecular Profiling in MPNs: Enhancing Diagnostic Insights

EP: 3.JAK V617F Monitoring and Risk Assessment Tools: Optimizing Treatment Decisions in MPN

EP: 4.Treatment Insights From RESPONSE: Ruxolitinib Therapy in Hydroxyurea-Resistant/Intolerant Disease

EP: 5.Advances in MPN Management: Insights From MANIFEST-2 and Beyond

EP: 6.Quality of Life in MPNs: Patient-Centered Factors That Shape Treatment Approaches

Now Viewing

EP: 7.Academic Perspectives on the Evolving Treatment Landscape in MPNs

Video content above is prompted by the following:

Please share your perspective on the future of care for patients with MPNs.

Recent Videos